loadpatents
name:-0.17425012588501
name:-0.18768000602722
name:-0.01531195640564
Pavlakis; George N. Patent Filings

Pavlakis; George N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pavlakis; George N..The latest application filed is for "codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells".

Company Profile
8.38.37
  • Pavlakis; George N. - Rockville MD
  • Pavlakis; George N. - Bethesda MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
Grant 11,339,198 - Felber , et al. May 24, 2
2022-05-24
Complexes of IL-15 and IL-15Ralpha and uses thereof
Grant 11,110,150 - Felber , et al. September 7, 2
2021-09-07
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
Grant 11,041,008 - Bergamaschi , et al. June 22, 2
2021-06-22
Use of IL-15 to increase thymic output and to treat lymphopenia
Grant 10,894,816 - Pavlakis , et al. January 19, 2
2021-01-19
Codon Optimized Il-15 And Il-15r-alpha Genes For Expression In Mammalian Cells
App 20200231643 - FELBER; Barbara K. ;   et al.
2020-07-23
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
Grant 10,428,133 - Felber , et al. October 1, 2
2019-10-01
Complexes Of Il-15 And Il-15ralpha And Uses Thereof
App 20190290734 - FELBER; Barbara K. ;   et al.
2019-09-26
Il-15r Alpha Forms, Cells Expressing Il-15r Alpha Forms, And Therapeutic Uses Of Il-15r Alpha And Il-15/il-15r Alpha Complexes
App 20190209653 - FELBER; Barbara K. ;   et al.
2019-07-11
IL-15 and IL-15R.alpha. heterodimer dose escalation regimens for treating conditions
Grant 10,335,460 - Felber , et al.
2019-07-02
Use Of Heterodimeric Il-15 In Adoptive Cell Transfer
App 20190117690 - Pavlakis; George N. ;   et al.
2019-04-25
Complexes of IL-15 and IL-15Ralpha and uses thereof
Grant 10,265,382 - Felber , et al.
2019-04-23
Heterodimers Of Il-15 And Il-15r Alpha To Increase Thymic Output And To Treat Lymphopenia
App 20190048056 - Bergamaschi; Cristina ;   et al.
2019-02-14
Methods And Compositions For Inducing An Immune Response Using Conserved Element Constructs
App 20180346520 - Felber; Barbara K. ;   et al.
2018-12-06
Use Of Il-15 To Increase Thymic Output And To Treat Lymphopenia
App 20180291075 - Pavlakis; George N. ;   et al.
2018-10-11
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
Grant 10,093,710 - Pavlakis , et al. October 9, 2
2018-10-09
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
Grant 9,975,937 - Pavlakis , et al. May 22, 2
2018-05-22
Cell expressing complexes of IL-15 and IL-15Ralpha
Grant 9,931,377 - Pavlakis , et al. April 3, 2
2018-04-03
Codon Optimized Il-15 And Il-15r-alpha Genes For Expression In Mammalian Cells
App 20180044392 - Felber; Barbara K. ;   et al.
2018-02-15
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
Grant 9,790,261 - Felber , et al. October 17, 2
2017-10-17
Heterodimers Of Il-15 And Il-15r Alpha To Increase Thymic Output And To Treat Lymphopenia
App 20170226174 - Pavlakis; George N. ;   et al.
2017-08-10
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
Grant 9,725,492 - Felber , et al. August 8, 2
2017-08-08
Il-15 And Il-15ralpha Heterodimer Dose Escalation Regimens For Treating Conditions
App 20170202924 - FELBER; Barbara K. ;   et al.
2017-07-20
Complexes Of Il-15 And Il-15ralpha And Uses Thereof
App 20170151310 - FELBER; Barbara K. ;   et al.
2017-06-01
Expression of IL-12 family heterodimers
Grant 9,546,202 - Felber , et al. January 17, 2
2017-01-17
Codon Optimized Il-15 And Il-15r-alpha Genes For Expression In Mammalian Cells
App 20160102128 - Felber; Barbara K. ;   et al.
2016-04-14
Codon Optimized Il-15 And Il-15r-alpha Genes For Expression In Mammalian Cells
App 20160096875 - Felber; Barbara K. ;   et al.
2016-04-07
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
Grant 9,303,080 - Felber , et al. April 5, 2
2016-04-05
Il-15r Alpha Forms, Cells Expressing Il-15r Alpha Forms, And Therapeutic Uses Of Il-15r Alpha And Il-15/il-15r Alpha Complexes
App 20150359853 - Felber; Barbara K. ;   et al.
2015-12-17
Use Of Il-15 Preparations To Treat Lymphopenia
App 20150246956 - Pavlakis; George N. ;   et al.
2015-09-03
Use of IL-15 preparations to treat lymphopenia
Grant 8,871,191 - Pavlakis , et al. October 28, 2
2014-10-28
Expression Of Il-12 Family Heterodimers
App 20140206758 - Felber; Barbara K. ;   et al.
2014-07-24
Expression of IL-12 family heterodimers
Grant 8,715,964 - Felber , et al. May 6, 2
2014-05-06
DNA immunization protocols
Grant 8,586,055 - Felber , et al. November 19, 2
2013-11-19
Dna-protein Vaccination Protocols
App 20130052221 - Felber; Barbara K. ;   et al.
2013-02-28
Use Of Il-15 Preparations To Treat Lymphopenia
App 20120141413 - Pavlakis; George N. ;   et al.
2012-06-07
Expression Vectors Able To Elicit Improved Immune Response And Methods Of Using Same
App 20120027792 - Pavlakis; George N. ;   et al.
2012-02-02
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
Grant 8,076,100 - Pavlakis December 13, 2
2011-12-13
Improved Expression Of Il-12 Family Heterodimers
App 20110166210 - Felber; Barbara K. ;   et al.
2011-07-07
Complexes Of Il-15 And Il-15ralpha And Uses Thereof
App 20110081311 - Pavlakis; George N. ;   et al.
2011-04-07
IL-12 for expression in mammalian cell
Grant 7,833,754 - Felber , et al. November 16, 2
2010-11-16
Dna Vaccination Protocols
App 20100285061 - Felber; Barbara ;   et al.
2010-11-11
Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions
Grant 7,608,422 - Pavlakis October 27, 2
2009-10-27
Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same
App 20090227664 - Pavlakis; George N. ;   et al.
2009-09-10
Dna-based Vaccination Of Retroviral-infected Individuals Undergoing Treatment
App 20090169503 - Felber; Barbara K. ;   et al.
2009-07-02
IL-12 for Expression in Mammalian Cell
App 20090137005 - Felber; Barbara ;   et al.
2009-05-28
Codon Optimized Il-15 And Il-15r-alpha Genes For Expression In Mammalian Cells
App 20090082299 - Felber; Barbara K. ;   et al.
2009-03-26
Liposome complexes for increased systemic delivery
Grant 7,288,266 - Smyth-Templeton , et al. October 30, 2
2007-10-30
Novel liposome complexes for increased systemic delivery
App 20060204566 - Smyth-Templeton; Nancy ;   et al.
2006-09-14
Novel post-transcriptional regulatory elements and uses thereof
App 20060188872 - Pavlakis; George N. ;   et al.
2006-08-24
Liposome complexes for increased systemic delivery
Grant 7,001,614 - Smyth-Templeton , et al. February 21, 2
2006-02-21
Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses
Grant 6,919,442 - Pavlakis , et al. July 19, 2
2005-07-19
Expression vectors able to elicit improved immune response and methods of using same
App 20040241140 - Pavlakis, George N. ;   et al.
2004-12-02
Novel liposome complexes for increased systemic delivery
App 20040197393 - Smyth-Templeton, Nancy ;   et al.
2004-10-07
Method of eliminating inhibitory/instability regions of mRNA
Grant 6,794,498 - Pavlakis , et al. September 21, 2
2004-09-21
Liposome complexes for increased systemic delivery
Grant 6,770,291 - Smyth-Templeton , et al. August 3, 2
2004-08-03
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
App 20040077577 - Pavlakis, George N.
2004-04-22
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
Grant 6,656,706 - Pavlakis December 2, 2
2003-12-02
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
App 20030049229 - Pavlakis, George N.
2003-03-13
Method of eliminating inhibitory/instability regions of mRNA
App 20020192660 - Pavlakis, George N. ;   et al.
2002-12-19
Novel liposome complexes for increased systemic delivery
App 20020122819 - Smyth-Templeton, Nancy ;   et al.
2002-09-05
Method of eliminating inhibitory/instability regions of mRNA
Grant 6,414,132 - Pavlakis , et al. July 2, 2
2002-07-02
Novel Liposome Complexes For Increased Systemic Delivery
App 20020028219 - SMYTH-TEMPLETON, NANCY ;   et al.
2002-03-07
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
App 20010036655 - Pavlakis, George N.
2001-11-01
Method of eliminating inhibitory/instability regions of mRNA
Grant 6,291,664 - Pavlakis , et al. September 18, 2
2001-09-18
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
Grant 6,265,548 - Pavlakis , et al. July 24, 2
2001-07-24
Method of eliminating inhibitory/instability regions from mRNA
Grant 6,174,666 - Pavlakis , et al. January 16, 2
2001-01-16
Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
Grant 6,027,881 - Pavlakis , et al. February 22, 2
2000-02-22
Nucleic acid constructs containing HIV genes with mutated inhibitory/instability regions and methods of using same
Grant 5,972,596 - Pavlakis , et al. October 26, 1
1999-10-26
Method of eliminating inhibitory/ instability regions of mRNA
Grant 5,965,726 - Pavlakis , et al. October 12, 1
1999-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed